Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 11, 1999, Pages 2714-2721

  Elias, Nizar ^a   Patterson, Bruce W ^a   Schonfeld, Gustav ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoprotein B; Familial hypobetalipoproteinemia; Stable isotopes; Triglycerides

Indexed keywords

APOLIPOPROTEIN B100; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID TRANSPORT; FEMALE; GAS CHROMATOGRAPHY; HETEROZYGOSITY; HUMAN; HYPOBETALIPOPROTEINEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL;

EID: 0032698343     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.11.2714     Document Type: Article

References (42)

1. Schonfeld G. The hypobetalipoproteinemias. Annu Rev Nutr. 1995;15:23-34.
2. Linton MF, Farese RV, Young SG. Familial hypobetalipoproteineraia. J Lipid Res. 1993;34:521-541.
3. Collins DR. Knott TG, Pease RJ, Powell LM, Wallis SC, Robertson S, Pullinger CR, Milne RM, Marcel YL, Humphries SE, Talmud PJ, Lloyd JK, Miller NE, Muller D, Scott J. Truncated variants of apolipoprotein B cause hypobetalipoproteinemia. Nucleic Acids Res. 1988;16:8361-8375.
4. Huang LS, Ripps ME, Korman SH, Deckelbaum RJ, Breslow JL. Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu recombination. J Biol Chem. 1989;264:11394-11400.
5. Huang LS, Kayden H, Sokol RJ, Breslow JL. ApoB gene nonsense and splicing mutations in a compound heterozygote for familial hypobetalipoproteinemia. J Lipid Res. 1991;32:1341-1348.
6. Parhofer KG, Barrett PHR, Bier DM, Schonfeld G. Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate (in vivo studies in apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotes). J Lipid Res. 1996;37:844-852.
7. Srivastava N, Noto D, Averna M, Pulai J, Srivastava RAK, Cole TG, Latour MA, Patterson BW, Schonfeld G. A new apolipoprotein B truncation (apoB 43.7) in familial hypobetalipoproteinemia: genetic and metabolic studies. Metabolism. 1996;45:1296-1304.
8. Parhofer KG, Barrett PHR, Bier DM, Schonfeld G. Lipoproteins containing the truncated apolipoprotein, apoB-89, are cleared from human plasma more rapidly than apoB-100 containing lipoproteins in vivo. J Clin Invest. 1992;89:1931-1937.
9. Krul ES, Parhofer KG, Barrett PHR, Wagner RD, Schonfeld G. ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies. J Lipid Res. 1992;33:1037-1050.
10. Aguilar-Salinas CA, Barrett PHR, Parhofer KG, Young SG, Tessareau D, Bateman J, Quinn C, Schonfeld G. Apolipoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein B. Arterioscler Thromb Vasc Biol. 1995;15:71-80.
11. Welty FK, Lichtenstein AH, Barrett PHR, Dolnikowski GG, Ordovas JM, Schaefer EJ. Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes. Arterioscler Thromb Vasc Biol. 1997;17:881-888.
12. Lewis GF. Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol. 1997;8:146-153.
13. Kissebah AH, Alfarsi S, Adams PW. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipidemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metabolism. 1981;30:856-868.
14. Melish G, Le NA, Ginsberg H, Steinberg D, Brown WV. Dissociation of apoprotein B and triglyceride production in very low density lipoproteins. Am J Physiol. 1980;239:E354-E362.
15. Steiner G, Reardon MF. A new model of human VLDL metabolism based on simultaneous studies of its apoB and triglyceride. Metabolism. 1983;32:342-347.
16. Wu J, Kim J, Li Q, Kwok PY, Cole TG, Cefalu B, Averna M, Schonfeld G. Known mutations of apoB account for only a small minority of hypobetalipoproteinemia. J Lipid Res. 1999;40:955-959.
17. Pulai JI, Hamideh Z, Kwok PY, Kim JH, Wu J, Schonfeld G. Donor splice mutation (665+1 G-T) in familial hypobetalipoproteinemia with no detectable apoB truncation. Am J Med Genet. 1998;80:218-220.
18. Klein RL, Zilversmit DB. Direct determination of human and rabbit apolipoprotein B selectively precipitated with butanol-isopropyl ether. J Lipid Res. 1984;25:1380-1386.
19. Adams RF. Determination of amino acid profiles in biological samples by gas chromatography. J Chromatogr. 1974;95:189-212.
20. Patterson BW, Hachey DL, Cook GL, Amann JM, Klein PD. Incorporation of a stable isotopically labeled amino acid into multiple human apolipoproteins. J Lipid Res. 1991;32:1063-1072.
21. Patterson BW, Zhao G, Klein S. Improved accuracy and precision of gas chromatography/mass spectrometry measurements for metabolic tracers. Metabolism. 1998;47:706-712.
22. Carson ER, Cobelli C, Finkelslein L. The Mathematical Modeling of Metabolic and Endocrine Systems. New York, NY: John Wiley & Sons Inc; 1983.
23. Parhofer KG, Barrett PHR, Bier DM, Schonfeld G. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes. J Lipid Res. 1991;32:1311-1323.
24. Zech LA, Grundy SM, Steinberg D, Berman M. Kinetic model for production and metabolism of very low density lipoprotein triglycerides: evidence for a slow production pathway and results for normolipidemic subjects. J Clin Invest. 1979;63:1262-1273.
25. Cohn JS, Wagner DA, Cohn SD, Millar JS, Schaefer EJ. Measurement of very low density and low density lipoprotein apolipoprotein (apo) B-100 and high density lipoprotein apo A-I production in human subjects using deuterated leucine: effect of fasting and feeding. J Clin Invest. 1990;85:804-811.
26. 3] leucine. J Lipid Res. 1992;33:907-914.
27. Quarfordt SH, Frank A, Shames DM, Berman M, Steinberg D. Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich diets. J Clin Invest. 1970;49:2281-2297.
28. Grundy SM, Mok HYI, Zech L, Steinberg D, Berman M. Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia. J Clin Invest. 1979;63:1274-1283.
29. Shumak SL, Zinman B, Zuniga-Guarjardo S, Poapst M, Steiner G. Triglyceride-rich lipoprotein metabolism during acute hyperinsulinemia in hypertriglyceridemic humans. Metabolism. 1988;37:461-466.
30. Aarsland A, Chinkes D, Wolfe RR. Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J Clin Invest. 1996;98:2008-2017.
31. Schwarz JM, Neese RA, Turner S, Dare D, Hellerstein MK. Short-term alterations in carbohydrate energy intake in humans. J Clin Invest. 1995;96:2735-2743.
32. Gibbons GF. Assembly and secretion of hepatic very low density lipoprotein. Biochem J. 1990;268:1-13.
33. Ginsberg HN. Synthesis and secretion of apolipoprotein B from cultured liver cells. Curr Opin Lipidol. 1995;6:275-280.
34. Srivastava RAK, Srivastava N, Averna M, Cefalu AB, Schonfeld G. Molecular bases of low production rates of apolipoprotein B-100 and truncated apoB-82 in a mutant HepG2 cell line generated by targeted modification of the apolipoprotein B gene. J Lipid Res. 1999;40:901-912.
35. Sniderman AD, Cianflone K. Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler Thromb. 1993;13:629-636.
36. Boren J, Rustaeus S, Olofsson SO. Studies on the assembly of apolipoprotein B100 and apoB48-containing very low density lipoprotein in McARH7777 cells. J Biol Chem. 1994;269:25879-25888.
37. Gordon DA, Jamil H, Gregg RE, Olofsson S-O, Boren J. Inhibition of the microsomal triglyceride transfer protein blocks the first step of apolipoprotein B lipoprotein assembly but not the addition of bulk core lipids in the second step. J Biol Chem. 1996;271:33047-33053.
38. Hamilton RL, Erickson SK, Havel RJ. Nascent VLDL assembly occurs in two steps in the endoplasmic reticulum (ER) of hepatocytes. In: Woodford XFP, Davignon J, Sniderman A, eds. Atherosclerosis. Amsterdam, Netherlands. Elsevier Science; 1995:414-418.
39. Hamilton RL, Wong JS, Cham CM, Nielsen LB, Young SG. Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiency. J Lipid Res. 1998;39:1543-1557.
40. Tarugi P, Lonardo A, Ballarini G, Grisendi A, Pulvirenti M, Bagni A, Calandra S. Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B. Gastroenterology. 1996;111:1125-1133.
41. Hagve TA, Myrseth LE, Schrumpf E, Blomhoff JP, Christophersen B, Elgjo K, Gjone E, Prydz H. Liver steatosis in hypobetalipoproteinemia. J Hepatol. 1991;13:104-111.
42. Wishingrad M, Paaso B, Garcia G. Fatty liver due to heterozygous hypobetalipoproteinemia. Am J Gastroenterol. 1994;89:1106-1107.